University of Cambridge, School of Clinical Medicine, Cambridge CB2 0QQ, UK.
Research Department of Surgical Biotechnology, Institute of Immunity & Transplantation, and Department of Renal Medicine, University College London, London NW3 2PF, UK.
Cell Immunol. 2020 Aug;354:104131. doi: 10.1016/j.cellimm.2020.104131. Epub 2020 May 19.
Non-HLA antibody responses following solid organ transplantation have become increasingly emphasised, with several large clinical series suggesting that such responses contribute to late graft failure. Many of the responses described recognise both recipient and donor moieties of the target antigen and thus represent auto-, rather than allo-immunity. Within this rapidly evolving field, many questions remain unanswered: what triggers the response; how innate and adaptive humoral autoimmunity integrate; and most pressingly, how autoimmunity contributes to graft damage and its relationship to other effector mechanisms of graft rejection. This review summarises recent clinical and experimental studies of humoral autoimmunity in transplant rejection, and considers some of the answers to these questions.
实体器官移植后非 HLA 抗体反应受到越来越多的关注,几个大型临床系列研究表明这些反应导致晚期移植物衰竭。许多描述的反应既识别靶抗原的受者和供者部分,因此代表自身免疫,而不是同种异体免疫。在这个快速发展的领域中,仍有许多问题尚未得到解答:是什么引发了反应;先天和适应性体液自身免疫如何整合;以及最紧迫的是,自身免疫如何导致移植物损伤以及与其他移植物排斥的效应机制的关系。这篇综述总结了最近关于移植排斥中体液自身免疫的临床和实验研究,并考虑了这些问题的一些答案。